EventsThe 3rd International Electronic Conference on Biomedicines
Published
This submission belongs to the session S2. Immunotherapy and Adverse Effects of the event The 3rd International Electronic Conference on Biomedicines
Published date
13 May, 2025
Academic Editor
author-avatarSerafino Fazio
Citation
Simon LLEDO, Samantha Conte, Thi-Thom Tran, Juliette Vahdat, Joseph Ciccolini, Emmanuel Fenouillet, Denis Puthier, Franck Thuny, Jennifer Cautela, Nathalie Lalevee, Combined in vivo and in cellulo approach to study the role of endothelial cells and the NLRP3 inflammasome in cardiac dysfunction associated with immune-mediated myocarditis, in Proceedings of The 3rd International Electronic Conference on Biomedicines, 12 May–15 May 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Combined in vivo and in cellulo approach to study the role of endothelial cells and the NLRP3 inflammasome in cardiac dysfunction associated with immune-mediated myocarditis

image
Emmanuel Fenouillet 1
image
Franck Thuny 6,7,8
1. Equipe 5, C2VN INSERM 1263, Marseille, France, France
2. Institut MarMaRa, Aix-Marseille Université, Marseille, France
3. CNRS UMR 7288, IBDM, Marseille, France, France
4. SMARTc, Marseille Protéomique - CRCM, Marseille, France, France
5. Tagc, UMR 1090, Marseille, France, France
6. Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, North Hospital, Hôpitaux Universitaires de Marseille - AP-HM, Marseille, France, France
7. Equipe 5, C2VN INSERM 1263, Marseille, France
8. Mediterranean Center of Cardio-Oncology, Aix-Marseille Université, Marseille, France
Abstract

Introduction: Immunotherapy improves cancer outcomes but can cause myocarditis, with high mortality risk. Immune checkpoint inhibitor-induced myocarditis (ICI-M) involves T cell and macrophage infiltration in the myocardium, leading to tissue necrosis. The NLRP3 inflammasome pathway, triggered by IFN-γ, is overexpressed in ICI-M patients.

Objective: To study ICI-M pathophysiology using a preclinical model to investigate electrophysiological disorders linked to myocardial immune infiltration, and to explore molecular mechanisms in an IPSC cellular model from ICI-M patients.

Method: The preclinical ICI-M model was performed by injecting murine melanocytic cells into BALB/c mice, treated with anti-PD1/anti-CTLA-4 therapy. IPSC-derived cardiomyocytes (CM) and endothelial cells (EC) from ICI-M patients and healthy donors were exposed to IFN-γ.

Results: A decrease in tumour volume (p<0.01) was observed in mice with ECG disturbances, showing reduced QRS (p<0.01) and T wave (p<0.01) amplitude, as well as shorter repolarisation time (p<0.05). Impaired cardiac function correlated with increased CD3 transcript (p<0.01) and PD-L1 overexpression in the myocardium. In hiPSC-derived CM and EC, IFN-γ (10 ng/ml, 72 h) upregulated immune-response genes (PD-L1, MHC-II, p<0.001) and NLRP3 inflammasome genes (GBP5, GBP6, NLRC5, p<0.0001). More dysregulated genes were found in EC (FDR 0%, 2,210 vs. 789 in CM) after treatment. These genes are linked to immune response, apoptosis, and inflammasome activation. HiPSC-ECs showed a decreased expression of cell communication genes and an increased expression of JAK-STAT/MAP Kinases, NF-κB, and cytokine production genes. The inflammasome activated by IFN-γ differed between cell types, with NLRP3 in CM and AIM2 in EC. HiPSC-ECs from ICI-M patients showed specific immune-response regulations, including PD-L2, TLR2 overexpression, and pro-inflammatory cytokines (CCL2, CCL5, IL-1β), linked to NLRP3 inflammasome activation.

Conclusion: Mice treated with ICI show ECG disturbances linked to myocardial inflammation. Our model highlights the key role of endothelial cells in the IFN-γ response and NLRP3 inflammasome regulation in ICI-M patient cells.

Keywords
Immuno-mediated myocarditis
NLRP3 inflammasome
Oral Presentation
Stimulation of the auricular vagus nerve in ST-Elevation Myocardial Infarction (STEMI)
Neuroprotective Effects of the Flowers of Camellia japonica var. Hagoromo: A Potential Candidate for Neurodegenerative Disease Treatment